Deep vein thrombosis
368 results
201 - 300
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO)- Idarucizumab can reverse anticoagulation of dabigatran
- Anticoagulation for perioperative thromboprophylaxis in people with cancer
- Methods for administering subcutaneous heparin during pregnancy: Cochrane systematic review
- Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
Extended DVT prophylaxis after hospital discharge in patients with elective hip arthroplasty - Vena caval filters for the prevention of pulmonary embolism
- Tranexamic acid may reduce bleeding after cesarean delivery, but with a risk of adverse effects
- Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE
- Thromboprophylaxis for trauma patients: Cochrane systematic review
- Aspirin no different than rivaroxaban for prevention of VTE after TKA or THA
- Simple risk score predicts severity of COPD exacerbations
- Simple risk model predicts risk of VTE after surgery
- Anticoagulants versus non‐steroidal anti‐inflammatories or placebo for treatment of venous thromboembolism
- Antithrombotic treatment after stroke due to intracerebral haemorrhage
- Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
- Treatment for femoral pseudoaneurysms: Cochrane systematic review
- Sclerotherapy for varicose veins
- Pulmonary embolism
- Surgery or lasers preferred to foam sclerotherapy for varicose veins
- Risk prediction model predicts VTE recurrence after initial thrombotic event
- Overweight in pregnancy
- Preoperative education for hip or knee replacement: Cochrane systematic review
- Leg oedema
- Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
- Antithrombotic agents in primary health care
- Total knee replacement more effective for pain and function than nonsurgical treatment
- Anticoagulants for acute ischaemic stroke
- Prophylactic anticoagulants for non‐hospitalised people with COVID‐19
- Edoxaban as effective as LMWH for treatment of cancer-associated VTE
- SR: poor-quality data suggests stem cell joint injections are safe, but of unclear benefit
- Routine CT scans for occult malignancy not useful in patients with unprovoked VTE
- Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Interventions for varicose veins and leg oedema in pregnancy
- Tranexamic acid for reducing mortality in emergency and urgent surgery
- Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization
- Injection sclerotherapy for varicose veins
- Compression therapy for prevention of post‐thrombotic syndrome
- ACCP 2016: updated guidelines for VTE
- Fixed-dose, subcutaneous, unfractionated heparin effective for VTE
- Tinzaparin no better than warfarin in preventing recurrent VTE in adults with cancer
- Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty: Cochrane systematic review
- Rutosides for prevention of post-thrombotic syndrome: Cochrane systematic review
- COVID-19 and other coronavirus infections
- Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins: Cochrane systematic review
- Vena caval filters for the prevention of pulmonary embolism
- Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review
- Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism
- Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
- Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement: Cochrane systematic review
- Compression therapy for treating post‐thrombotic syndrome
- YEARS clinical decision tool decreases CT angiography in patients with suspected PE
- YEARS algorithm helpful for evaluating suspected PE in pregnant women
- Extended anticoagulation may be helpul for patients with unprovoked VTE or PE
- Lenalidomide effective for relapsed multiple myeloma
- Femoral lines not associated with increased risk of bloodstream infections
- Edoxaban noninferior to warfarin for venous thromboembolism anticoagulation
- Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases
- Postoperative tamoxifen for ductal carcinoma in situ
- Risk‐reducing medications for primary breast cancer: a network meta‐analysis
- Lower leg fractures
- Statins for primary prevention of venous thromboembolism
- Vascular closure devices for femoral arterial puncture site haemostasis
- Adder (Vipera berus) bite
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
- Pulmonary embolism rule-out criteria reduces the need for CT pulmonary angiography in low-risk patients (PERC)
- Thromboprophylaxis with apixaban prevents VTE in high-risk cancer patients (AVERT); jury still out on rivaroxaban (CASSINI)
- Apixaban is noninferior to dalteparin for venous thromboembolism associated with cancer
- Prevalence of pulmonary embolism is 5.9% in patients with COPD who are hospitalized with acute respiratory symptoms
- Apixaban slightly more effective and safe than warfarin, but more expensive
- Small benefit to extended treatment with apixaban in selected patients with VTE
- Perioperative bridging anticoagulation unhelpful for invasive procedures
- Positioning and spinal bracing for pain relief in metastatic spinal cord compression in adults
- Short term benefits for laparoscopic colorectal resection
- Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta‐analysis
- Low-molecular-weight heparins vs. standard heparin for acute ischaemic stroke
- Interventions for lowering plasma homocysteine levels in dialysis patients
- Anticoagulants for people hospitalised with COVID‐19
- Optimal treatment of acute venous thromboembolism
- Caesarean section versus vaginal delivery for preterm birth in singletons
- Self‐monitoring and self‐management of oral anticoagulation
- Warfarin initiation nomograms for venous thromboembolism: Cochrane systematic review
- Pentasaccharides for the prevention of venous thromboembolism: Cochrane systematic review
- Continuous vs. intermittent physiological monitoring for acute stroke
- Peripherally inserted central catheter design and material for reducing catheter failure and complications
- Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies
- Treatment of gestational diabetes mellitus to a tighter glycemic target is not beneficial